Each month, this advisory presents the best stock for the current market conditions. You will build a diversified portfolio of the best growth, momentum, value, international and dividend stocks for a very affordable price.
Tim Lutts is not only the Chief Analyst of Cabot Stock of the Month, he is also Cabot’s Chief Investment Strategist. This puts Tim in a unique position to select the most attractive stock from five Cabot advisories.
Cabot Stock of the Month recommends one stock each month from five other Cabot advisories, including value stocks, growth stocks, momentum stocks, dividend stocks and international stocks, depending on what appears to be the most promising stock for the current market conditions. The advisory does not present a model portfolio—i.e., there's no cash position, weightings, etc.; however, all recommendations are followed up weekly with buy, hold and eventually sell ratings. The performance shown is the average gain of Cabot Stock of the Month's current holdings, as of 6/29/15.
105% in Stryker
78% in Melco Crown Entertainment
72% in Express Scripts
69% in Salix Pharmaceuticals
Try Cabot Stock of the Month risk-free for 12 months.
What our Customers say about Cabot Stock of the Month
Tim, Thank you for your advice. All 3 of your picks are great. BIIB is going to the moon. I bought SLXP this morning. Sold YY last week with some substantial gain. Cabot is the best. My great appreciation to you, Mike and Paul.
A. S., Laguna Beach, California
I am "blown away" by the value I receive from the Cabot group. You offer even more than promised. Kindest regards,
Sophia Z., Long Island City, New York
I keep reading your letters with great interest and I want you to count on my respect and my support from now on. I appreciate your letter along with your recommendations. Best regards, Timothy, I look forward to keep doing business with you and your team, a great team I am sure.
A. Cloutier, Quebec, Canada
Are you ready to get started with your risk-free trial subscription?